Covered recipient · General Payments record
STEPHEN M ISRAEL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$630.12
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $565.38 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $358.96 | 27 |
| UCB, Inc. | $41.59 | 1 |
| ABBVIE INC. | $31.79 | 2 |
| Genentech USA, Inc. | $29.08 | 1 |
| PFIZER INC. | $27.75 | 2 |
| Lilly USA, LLC | $24.42 | 1 |
| Averitas Pharma Inc. | $23.68 | 1 |
| Amneal Pharmaceuticals LLC | $14.84 | 1 |
| Lundbeck LLC | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107386388 | CMS |
| ABBVIE INC. | $15.97 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107386390 | CMS |
| Amneal Pharmaceuticals LLC | $14.84 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139211678 | CMS |
| Averitas Pharma Inc. | $23.68 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133461847 | CMS |
| Biogen, Inc. | $10.89 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870108 | CMS |
| Biogen, Inc. | $11.00 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104820680 | CMS |
| Biogen, Inc. | $1.78 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872348 | CMS |
| Biogen, Inc. | $7.61 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879372 | CMS |
| Biogen, Inc. | $4.38 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872350 | CMS |
| Biogen, Inc. | $13.01 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104844940 | CMS |
| Biogen, Inc. | $2.76 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104841734 | CMS |
| Biogen, Inc. | $14.04 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104859382 | CMS |
| Biogen, Inc. | $28.45 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875438 | CMS |
| Biogen, Inc. | $28.60 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104809217 | CMS |
| Biogen, Inc. | $7.57 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104818434 | CMS |
| Biogen, Inc. | $7.68 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846036 | CMS |
| Biogen, Inc. | $14.53 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104853744 | CMS |
| Biogen, Inc. | $9.28 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104815111 | CMS |
| Biogen, Inc. | $13.56 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104825984 | CMS |
| Biogen, Inc. | $15.12 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104848048 | CMS |
| Biogen, Inc. | $11.05 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104868938 | CMS |
| Biogen, Inc. | $28.73 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870898 | CMS |
| Biogen, Inc. | $13.32 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104823712 | CMS |
| Biogen, Inc. | $18.30 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104814749 | CMS |
| Biogen, Inc. | $12.19 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104833145 | CMS |
| Biogen, Inc. | $18.17 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104838128 | CMS |
| Biogen, Inc. | $4.95 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104868940 | CMS |
| Biogen, Inc. | $14.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858238 | CMS |
| Biogen, Inc. | $19.93 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104816989 | CMS |
| Biogen, Inc. | $13.95 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104852580 | CMS |
| Biogen, Inc. | $13.51 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104833905 | CMS |
| Genentech USA, Inc. | $29.08 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133190286 | CMS |
| Lilly USA, LLC | $24.42 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135915683 | CMS |
| Lundbeck LLC | $13.27 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039269 | CMS |
| PFIZER INC. | $13.20 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131762370 | CMS |
| PFIZER INC. | $14.55 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131486802 | CMS |
| UCB, Inc. | $41.59 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143126946 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.